Wednesday, June 14, 2017 8:58:07 AM
CBIO - 4.32 Pre-market at 4.45/4.50
Catalyst Biosciences, ISU Abxis Complete Dosing Patients in Hemophilia B Clinical Trial; Shares Up 5% Pre Bell
Catalyst Biosciences, ISU Abxis Complete Dosing Patients in Hemophilia B Clinical Trial; Shares Up 5% Pre Bell
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
